114 related articles for article (PubMed ID: 32979402)
1. Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein.
Battagliotti JM; Fontana D; Etcheverrigaray M; Kratje R; Prieto C
Antiviral Res; 2020 Nov; 183():104936. PubMed ID: 32979402
[TBL] [Abstract][Full Text] [Related]
2. Development, Production, and Characterization of Hepatitis B Subviral Envelope Particles as a Third-Generation Vaccine.
Battagliotti JM; Fontana D; Etcheverrigaray M; Kratje R; Prieto C
Methods Mol Biol; 2022; 2410():273-287. PubMed ID: 34914052
[TBL] [Abstract][Full Text] [Related]
3. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
[TBL] [Abstract][Full Text] [Related]
4. Efficient cellular and humoral immune response and production of virus-neutralizing antibodies by the Hepatitis B Virus S/preS1
Pantazica AM; Dobrica MO; Lazar C; Scurtu C; Tucureanu C; Caras I; Ionescu I; Costache A; Onu A; Clarke JL; Stavaru C; Branza-Nichita N
Front Immunol; 2022; 13():941243. PubMed ID: 35935966
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
6. Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine.
Beaumont E; Roingeard P
Vaccine; 2015 Feb; 33(8):973-6. PubMed ID: 25596457
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
Ho JK; Jeevan-Raj B; Netter HJ
Viruses; 2020 Jan; 12(2):. PubMed ID: 31973017
[No Abstract] [Full Text] [Related]
8. Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.
Prange R; Werr M; Birkner M; Hilfrich R; Streeck RE
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2131-40. PubMed ID: 7561750
[TBL] [Abstract][Full Text] [Related]
9. A modified hepatitis B virus surface antigen with the receptor-binding site for hepatocytes at its C terminus: expression, antigenicity and immunogenicity.
Xu X; Li GD; Kong YY; Yang HL; Zhang Z; Cao HT; Wang Y
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3673-7. PubMed ID: 7527840
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
11. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) protein.
Yamada T; Iwabuki H; Kanno T; Tanaka H; Kawai T; Fukuda H; Kondo A; Seno M; Tanizawa K; Kuroda S
Vaccine; 2001 Apr; 19(23-24):3154-63. PubMed ID: 11312011
[TBL] [Abstract][Full Text] [Related]
14. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein.
Dobrica MO; Lazar C; Paruch L; Skomedal H; Steen H; Haugslien S; Tucureanu C; Caras I; Onu A; Ciulean S; Branzan A; Clarke JL; Stavaru C; Branza-Nichita N
Antiviral Res; 2017 Aug; 144():256-265. PubMed ID: 28666757
[TBL] [Abstract][Full Text] [Related]
15. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
[TBL] [Abstract][Full Text] [Related]
16. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
17. Humoral Immune Response in Mice Elicited by Combined Yeast-Derived Hepatitis B Virus Core, Surface, and Mosaic Surface Antigens.
Granovski V; Yokosawa J; Rodrigues-Granovski V; Castro CC; Urbina AC; Granovski N
Intervirology; 2017; 60(3):90-101. PubMed ID: 28957812
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
20. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
